Skip to main content
. 2023 Aug 7;15(15):4011. doi: 10.3390/cancers15154011

Figure 2.

Figure 2

Post-transplant period until diagnosis of malignancy. Lung cancer: 52 ± 42 months [95%CI: 33–71]. Digestive neoplasms: 79 ± 70 months [95%CI: 25–133]. Hematological (post-transplant lymphoproliferative disease—PTLD): 72 ± 34 months [95%CI: 52–91]. Skin neoplasms (non-melanoma): 66 ± 51 months [95%CI: 46–86]. Urological: 74 ± 67 months [95%CI: 17–130]. ORL: 89 ± 43 months [95%CI: 16–196]. Gynecological malignancies: 33 ± 11 months [95%CI: 4–61]. Central nervous system (CNS): 54 ± 36 months. Breast cancer: 13 ± 10 months.